Tenofovir 1% vaginal gel: Phase IIb data

Researchers at the Centre for the AIDS Program of Research in South Africa (CAPRISA) and colleagues reported data from the double-blind, South African Phase IIb CAPRISA 004 trial in 889 sexually activ...